NASDAQ:CLDX

Celldex Therapeutics, Inc Earning Date

USA |NASDAQ |USD

CLDX Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 3, 2021 Sep 2021 $-0.36 $-0.34 $-0.36
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 3, 2021 Sep 2021 $1.22M $3.48M $668.00K

Celldex Therapeutics, Inc's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 2021.

CLDX Earnings Date & History Chart

CLDX Earnings & Revenue Forecast

CLDX Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 6 $-0.38 $-0.44 $-0.35
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 5 $-1.50 $-1.61 $-1.43
Dec 2022 5 $-1.73 $-1.95 $-1.51

CLDX Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.38 $-0.39 $-0.39
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-1.51 $-1.58 $-1.58
Dec 2022 0 / 0 $-1.69 $-1.77 $-1.60

CLDX Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 5 $1.12M $0.00 $3.48M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 5 $6.53M $4.20M $11.13M
Dec 2022 5 $2.30M $0.00 $5.00M

CLDX Earnings Date & Revenue History

CLDX Earnings History

|
Show More
Show More

CLDX Revenue History

|
Show More
Show More

Celldex Therapeutics, Inc Next Earnings Date & Report

CLDX Next Earnings Date & Report Preview: Sep 2021 (FQ)

CLDX's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 6 analysts, the average EPS estimation for Celldex Therapeutics, Inc's next quarterly earnings is $-0.36, with a low EPS estimation of $-0.42, and a high estimation of $-0.32.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.37, the last 2 month trend is $-0.39, and the 3 month trend is $-0.40.

Based on 5 analysts, the average revenue estimation is $1.22M, with a low revenue estimation of $0.00, and a high estimation of $3.48M.

Celldex Therapeutics, Inc Previous Earnings Dates & Reports

CLDX Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Celldex Therapeutics, Inc's previous earnings date was Aug 5, 2021 for its fiscal quarter ended Jun 30, 2021.

CLDX's earnings per share (EPS) was $-0.34, beating the consensus analysts forecast of $-0.40 by 15.00%.

The EPS was higher than the previous fiscal quarter (Mar 2021) by -19.05%, and higher than the same period a year before (Jun 2020) by -32.00%.

Revenues were $3.48M, up by 408.03% from the previous quarter , and up by 1374.58% from the same period last year.

The company reported a net income of $-13.37M.

Free cash flow for the quarter was $-12.07M , compared to $-18.65M last quarter and $-12.13M a year before.

CLDX ended the quarter with $2.78M in total debt, a decrease of -11.45% compared to the previous quarter, and a decrease of -8.65% compared to the same quarter a year before.

CLDX Previous Earnings Date & Report Recap: Dec 2020 (FY)

Celldex Therapeutics, Inc's previous annual earnings date was Mar 29, 2021 for its fiscal year ended Dec 31, 2020.

CLDX's earnings per share (EPS) was $-2.14, missing the consensus analysts forecast of $-1.77 by 20.90% , and higher than the previous year's EPS (Dec 2019) by -41.05%.

Revenues were $7.42M, better than the forecast of $4.20M by 76.62%, and up by 107.61% from previous year's revenue.

The company reported a net income of $-59.78M.

Celldex Therapeutics, Inc reported a free cash flow of $-41.96M for its fiscal year, compared to $-47.15M a year ago.

The company ended the fiscal year with $3.48M in total debt, a decrease of -4.81% compared to the previous year.